Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis

Science Translational Medicine

Volumn 7, Issue 271, 2015, Pages

  Zhao, Yuechao ^a   Gong, Ping ^a   Chen, Yiru ^a   Nwachukwu, Jerome C ^b   Srinivasan, Sathish ^b   Ko, CheMyong ^c   Bagchi, Milan K ^a   Taylor, Robert N ^d   Korach, Kenneth S ^e   Nettles, Kendall W ^b   Katzenellenbogen, John A ^c   Katzenellenbogen, Benita S ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROINDAZOLE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INDAZOLE DERIVATIVE; OXABICYCLOHEPTENE SULFONATE; RNA; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ESTROGEN; LETROZOLE; LIGAND; NITRILE; TRIAZOLE DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYST; DISEASE COURSE; EMBRYONIC STEM CELL; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; KNOCKOUT MOUSE; LIQUID CHROMATOGRAPHY; MACROPHAGE; MASS SPECTROMETRY; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; STROMA CELL; VASCULARIZATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL SURVIVAL; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; FERTILITY; INFLAMMATION; METABOLISM; NERVE CELL; PATHOLOGY; TRANSGENIC MOUSE; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; EMBRYONIC STEM CELLS; ENDOMETRIOSIS; ESTROGENS; FEMALE; FERTILITY; HUMANS; INDAZOLES; INFLAMMATION; LIGANDS; MACROPHAGES; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; NITRILES; RECEPTORS, ESTROGEN; STROMAL CELLS; TREATMENT OUTCOME; TRIAZOLES;

EID: 84921725208     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3010626     Document Type: Article

References (45)

1. A. Asante, R. N. Taylor, Endometriosis: The role of neuroangiogenesis. Annu. Rev. Physiol. 73, 163-182 (2011).
2. S. E. Bulun, Endometriosis. N. Engl. J. Med. 360, 268-279 (2009).
3. L. C. Giudice, L. C. Kao, Endometriosis. Lancet 364, 1789-1799 (2004).
4. S. J. Han, S. M. Hawkins, K. Begum, S. Y. Jung, E. Kovanci, J. Qin, J. P. Lydon, F. J. DeMayo, B. W. O'Malley, A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nat. Med. 18, 1102-1111 (2012).
5. K. J. Berkley, A. J. Rapkin, R. E. Papka, The pains of endometriosis. Science 308, 1587-1589 (2005).
6. B. Toth, Stress, inflammation and endometriosis: Are patients stuck between a rock and a hard place? J. Mol. Med. 88, 223-225 (2010).
7. E. Attar, S. E. Bulun, Aromatase and other steroidogenic genes in endometriosis: Translational aspects. Hum. Reprod. Update 12, 49-56 (2006).
8. S. E. Bulun, D. Monsavais, M. E. Pavone, M. Dyson, Q. Xue, E. Attar, H. Tokunaga, E. J. Su, Role of estrogen receptor-b in endometriosis. Semin. Reprod. Med. 30, 39-45 (2012).
9. F. M. Reis, F. Petraglia, R. N. Taylor, Endometriosis: Hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum. Reprod. Update 19, 406-418 (2013).
10. M. De Angelis, F. Stossi, K. A. Carlson, B. S. Katzenellenbogen, J. A. Katzenellenbogen, Indazole estrogens: Highly selective ligands for the estrogen receptor β. J. Med. Chem. 48, 1132-1144 (2005).
11. K. W. Nettles, J. B. Bruning, G. Gil, J. Nowak, S. K. Sharma, J. B. Hahm, K. Kulp, R. B. Hochberg, H. Zhou, J. A. Katzenellenbogen, B. S. Katzenellenbogen, Y. Kim, A. Joachmiak, G. L. Greene, NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nat. Chem. Biol. 4, 241-247 (2008).
12. K. Saijo, J. G. Collier, A. C. Li, J. A. Katzenellenbogen, C. K. Glass, An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 145, 584-595 (2011).
13. H. B. Zhou, J. S. Comninos, F. Stossi, B. S. Katzenellenbogen, J. A. Katzenellenbogen, Synthesis and evaluation of estrogen receptor ligands with bridged oxabicyclic cores containing a diarylethylene motif: Estrogen antagonists of unusual structure. J. Med. Chem. 48, 7261-7274 (2005).
14. C. M. Becker, R. D. Wright, R. Satchi-Fainaro, T. Funakoshi, J. Folkman, A. L. Kung, R. J. D'Amato, A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. Am. J. Pathol. 168, 2074-2084 (2006).
15. J. Kulak Jr., C. Fischer, B. Komm, H. S. Taylor, Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model. Endocrinology 152, 3226-3232 (2011).
16. M. Bilotas, G. Meresman, I. Stella, C. Sueldo, R. I. Barañao, Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis. Fertil. Steril. 93, 2513-2518 (2010).
17. A. Akoum, A. Lemay, I. Paradis, N. Rheault, R. Maheux, Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids. Hum. Reprod. 11, 2269-2275 (1996).
18. A. Bergqvist, C. Bruse, M. Carlberg, K. Carlström, Interleukin 1β, interleukin-6, and tumor necrosis factor-α in endometriotic tissue and in endometrium. Fertil. Steril. 75, 489-495 (2001).
19. D. Hornung, I. P. Ryan, V. A. Chao, J. L. Vigne, E. D. Schriock, R. N. Taylor, Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J. Clin. Endocrinol. Metab. 82, 1621-1628 (1997).
20. R. González-Ramos, S. Defrère, L. Devoto, Nuclear factor-kappaB: A main regulator of inflammation and cell survival in endometriosis pathophysiology. Fertil. Steril. 98, 520-528 (2012).
21. V. Anaf, I. El Nakadi, V. De Moor, C. Chapron, G. Pistofidis, J. C. Noel, Increased nerve density in deep infiltrating endometriotic nodules. Gynecol. Obstet. Invest. 71, 112-117 (2011).
22. S. Mechsner, J. Schwarz, J. Thode, C. Loddenkemper, D. S. Salomon, A. D. Ebert, Growthassociated protein 43-positive sensory nerve fibers accompanied by immature vessels are located in or near peritoneal endometriotic lesions. Fertil. Steril. 88, 581-587 (2007).
23. V. Anaf, P. Simon, I. El Nakadi, I. Fayt, T. Simonart, F. Buxant, J. C. Noel, Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum. Reprod. 17, 1895-1900 (2002).
24. S. L. McAllister, K. A. McGinty, D. Resuehr, K. J. Berkley, Endometriosis-induced vaginal hyperalgesia in the rat: Role of the ectopic growths and their innervation. Pain 147, 255-264 (2009).
25. F. D. De Leon, R. Vijayakumar, C. V. Rao, M. Yussman, Prostaglandin F2 alpha and E2 release by peritoneum with and without endometriosis. Int. J. Fertil. 33, 48-51 (1988).
26. J. C. Petruska, L. M. Mendell, The many functions of nerve growth factor: Multiple actions on nociceptors. Neurosci. Lett. 361, 168-171 (2004).
27. O. Bukulmez, D. B. Hardy, B. R. Carr, R. A. Word, C. R. Mendelson, Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology 149, 1190-1204 (2008).
28. E. Attar, S. E. Bulun, Aromatase inhibitors: The next generation of therapeutics for endometriosis? Fertil. Steril. 85, 1307-1318 (2006).
29. S. Ferrero, D. J. Gillott, P. L. Venturini, V. Remorgida, Use of aromatase inhibitors to treat endometriosis-related pain symptoms: A systematic review. Reprod. Biol. Endocrinol. 9, 89 (2011).
30. K. A. Burns, K. F. Rodriguez, S. C. Hewitt, K. S. Janardhan, S. L. Young, K. S. Korach, Role of estrogen receptor signaling required for endometriosis-like lesion establishment in a mouse model. Endocrinology 153, 3960-3971 (2012).
31. S. E. Bulun, Y.H. Cheng, M. E. Pavone, Q. Xue, E. Attar, E. Trukhacheva, H. Tokunaga, H. Utsunomiya, P. Yin, X. Luo, Z. Lin, G. Imir, S. Thung, E. J. Su, J. J. Kim, Estrogen receptor-b, estrogen receptor-a, and progesterone resistance in endometriosis. Semin. Reprod. Med. 28, 36-43 (2010).
32. M. T. Beste, N. Pfäffle-Doyle, E. A. Prentice, S. N. Morris, D. A. Lauffenburger, K. B. Isaacson, L. G. Griffith, Molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation. Sci. Transl. Med. 6, 222ra216 (2014).
33. M. Bacci, A. Capobianco, A. Monno, L. Cottone, F. Di Puppo, B. Camisa, M. Mariani, C. Brignole, M. Ponzoni, S. Ferrari, P. Panina-Bordignon, A. A. Manfredi, P. Rovere-Querini, Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am. J. Pathol. 175, 547-556 (2009).
34. J. McLaren, A. Prentice, D. S. Charnock-Jones, S. A. Millican, K. H. Müller, A. M. Sharkey, S. K. Smith, Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest. 98, 482-489 (1996).
35. B. Calippe, V. Douin-Echinard, L. Delpy, M. Laffargue, K. Lélu, A. Krust, B. Pipy, F. Bayard, J. F. Arnal, J. C. Guéry, P. Gourdy, 17β-Estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor a signaling in macrophages in vivo. J. Immunol. 185, 1169-1176 (2010).
36. K. Lélu, S. Laffont, L. Delpy, P. E. Paulet, T. Périnat, S. A. Tschanz, L. Pelletier, B. Engelhardt, J. C. Guéry, Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J. Immunol. 187, 2386-2393 (2011).
37. W. F. Wu, X. J. Tan, Y. B. Dai, V. Krishnan, M. Warner, J. A. Gustafsson, Targeting estrogen receptor b in microglia and T cells to treat experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 110, 3543-3548 (2013).
38. A. Akoum, C. Jolicoeur, A. Boucher, Estradiol amplifies interleukin-1-induced monocyte chemotactic protein-1 expression by ectopic endometrial cells of women with endometriosis. J. Clin. Endocrinol. Metab. 85, 896-904 (2000).
39. H. A. Harris, K. L. Bruner-Tran, X. Zhang, K. G. Osteen, C. R. Lyttle, A selective estrogen receptor-b agonist causes lesion regression in an experimentally induced model of endometriosis. Hum. Reprod. 20, 936-941 (2005).
40. S. Dupont, A. Krust, A. Gansmuller, A. Dierich, P. Chambon, M. Mark, Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes. Development 127, 4277-4291 (2000).
41. S. C. Hewitt, G. E. Kissling, K. E. Fieselman, F. L. Jayes, K. E. Gerrish, K. S. Korach, Biological and biochemical consequences of global deletion of exon 3 from the ERα gene. FASEB J. 24, 4660-4667 (2010).
42. Z. Fang, S. Yang, B. Gurates, M. Tamura, E. Simpson, D. Evans, S. E. Bulun, Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. J. Clin. Endocrinol. Metab. 87, 3460-3466 (2002).
43. A. Sahores, G. M. Luque, V. Wargon, M. May, A. Molinolo, D. Becu-Villalobos, C. Lanari, C. A. Lamb, Novel, low cost, highly effective, handmade steroid pellets for experimental studies. PLOS One 8, e64049 (2013).
44. I. P. Ryan, E. D. Schriock, R. N. Taylor, Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J. Clin. Endocrinol. Metab. 78, 642-649 (1994).
45. Y. Zhao, S. Park, M. K. Bagchi, R. N. Taylor, B. S. Katzenellenbogen, The coregulator, repressor of estrogen receptor activity (REA), is a crucial regulator of the timing and magnitude of uterine decidualization. Endocrinology 154, 1349-1360 (2013).